Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan

Toshio Naitoa Department of General Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

Yan Yanb Department of Palliative Medicine, Juntendo University Graduate School of Medicine, Tokyo, JapanCorrespondence[email protected]

Yoko Tabec Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

Kuniaki Seyamad Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information

Gautam A. Deshpandea Department of General Medicine, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information

References

Our World in Data. [accessed 2021 Aug 27]. https://ourworldindata.org/covid-vaccinations.
Google Scholar
Saita M, Yan Y, Ito K, Sasano H, Seyama K, Naito T. Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers in Japan. J Infect Chemother. 2021 Sep 16;S1341–321X(21):00258-0. Online ahead of print.
Web of Science ®Google Scholar
Angel Y, Spitzer A, Henig O, Saiag E, Sprecher E, Padova H, Ben-Ami R. Association between vaccination with BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among health care workers. JAMA. 2021 Jun 22;325(24):2457–65. doi:10.1001/jama.2021.7152.
PubMed Web of Science ®Google Scholar
Gohil SK, Olenslager K, Quan KA, Dastur CK, Afsar N, Chang W, Huang SS. Asymptomatic and symptomatic COVID-19 infections among health care personnel before and after vaccination. JAMA Netw Open. 2021 Jul 1;4(7):e2115980. doi:10.1001/jamanetworkopen.2021.15980.
PubMed Web of Science ®Google Scholar